Don''t Forget Polak.........
Thats right polak.......also include
---- In talks to acquire another technology that can be partnered in the future (as mentioned by Dr. Cruz)
---Move E1-INT into larger Phasellb (with or without novo) (but in conversation with and with input from Novo for the Phasellb design)
---Share Consolidation (makes investment in TTH marginable)(as approved by over 99% of shareholders)
---US Listing (timeline was 3-6 months 2 weeks ago)
Lets not forget as well it's the FDA Approved MAD AZ-103Phasel Trial polak mentions........
With clear signs of efficacy in humans established for INT, the talks for GLP1-INT Partnership should be given a positive boost for our negotiating team.
Good pick on the shares today polak........... you bettered me!! Bought back my traders , I sold @ $2.20ish, for $1.70ish today. Considering increasing my long position if further weakness prevails in the next few weeks going into MAD AZD-103 News and whats looking like will be a very active summer for Transition with E1-INT 6 month Data in late June and Novos Decision within 2 months of that. Commencement of Phasell AZD-103 in there as well. Share Consolidation and US Listing slated to occur in summer as well. She's shaping up to be a news filled summer this year!!